Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts
Author(s) -
Kristopher A. Lyon,
Jason H. Huang
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.08.19
Subject(s) - glioblastoma , bevacizumab , medicine , adjuvant , adjuvant therapy , oncology , brain tumor , surgery , cancer , chemotherapy , pathology , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom